The global market for point of care diagnostics is projected to grow significantly, reaching approximately US$ 70.89 billion by 2027, up from US$ 26.60 billion in 2018. This growth trajectory indicates a compound annual growth rate (CAGR) of 11.8% from 2019 to 2027.
Several factors are driving the expansion of the point of care diagnostics market. The rising prevalence of infectious diseases, along with continuous product launches and advancements in product development, are key contributors. Additionally, the increasing availability of CLIA-waived point of care (POC) tests has further bolstered market growth. Emerging markets in developing nations are also expected to positively influence the market's expansion in the foreseeable future. However, challenges such as product recalls may hinder growth prospects in the coming years.
Point of care testing (POCT) refers to medical diagnostic testing conducted at or near the site of patient care, providing immediate information to healthcare providers regarding a patient's condition. POCT serves as a crucial diagnostic tool utilized in various hospital settings, including critical care environments like the intensive care unit (ICU), operating room (OR), and emergency department (ED).
Despite the promising growth, the market faces potential setbacks due to product recalls. Such recalls can significantly impact market growth during the forecast period, particularly in light of global supply chain complexities and increasingly stringent regulatory requirements. For instance, in 2018, the PTS Panels CHOL+GLU test strips, classified as in vitro diagnostic medical devices (IVDs), were recalled in Australia. This recall was prompted by concerns regarding the potential loss of glucose analyte activity before the designated shelf life. According to the Therapeutic Goods Administration, these devices, produced by Point Of Care Diagnostics Australia Pty Ltd, exhibited a risk of under-recovery of glucose analyte, which could lead to inaccurate glucose test results. Such inaccuracies may delay disease diagnosis, ultimately undermining consumer confidence in point of care devices.
The global point of care diagnostics market is categorized based on product type, prescription mode, and end user. In terms of product segmentation, the market includes glucose monitoring products, infectious disease testing products, cardiometabolic testing products, pregnancy and fertility testing products, coagulation testing products, tumor/cancer marker testing products, cholesterol testing products, urinalysis testing products, hematology testing products, and various other POC products. In 2018, glucose monitoring products dominated the market share within the product category.
Regarding prescription mode, the market is divided into prescription-based testing and over-the-counter (OTC) testing. Additionally, the end user segmentation encompasses professional diagnostic centers, home care settings, research laboratories, and other categories.
To compile the report, a variety of primary and secondary sources were utilized, including reputable organizations such as the Food and Drug Administration, World Health Organization, Public Health Agency of Canada, Canadian Diabetes Association, National Healthcare Safety Network (NHSN), International Diabetes Federation, Diabetes Education Society of South Africa (DESSA), Canadian Breast Cancer Foundation, National Cancer Institute (NCI), National Institute of Cancer Prevention and Research (NICPR), and the Pancreatic Cancer Network South Africa, among others.
In summary, the point of care diagnostics market is on a robust growth path, driven by various factors including the rising incidence of infectious diseases and advancements in testing technologies. However, the market must navigate challenges such as product recalls and regulatory hurdles to maintain its growth momentum.
TABLE OF CONTENTS
1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
 3.2.1 Hypothesis formulation:
 3.2.2 Macro-economic factor analysis:
 3.2.3 Developing base number:
 3.2.4 Data Triangulation:
 3.2.5 Country level data:
4. Point of Care Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Point of Care Diagnostics Market - Key Market Dynamics
5.1 Point of Care Diagnostics Market - Key Market Dynamics
5.2 Market Drivers
 5.2.1 Increasing Prevalence of Infectious Diseases
 5.2.2 Key Product Launches and Developments
5.3 Market Restraints
 5.3.1 Product Recalls
5.4 Market Opportunities
 5.4.1 Rising Product Launches and Advancements by Market Players in Emerging Economies
5.5 Future Trends
 5.5.1 Integration Of Artificial Intelligence (AI) and Machine Learning (ML)
5.6 Impact of Drivers and Restraints:
6. Point of Care Diagnostics Market - Global Market Analysis
6.1 Point of Care Diagnostics Market Revenue (US$ Million), 2021-2031
6.2 Point of Care Diagnostics Market Forecast Analysis
7. Point of Care Diagnostics Market Analysis - by Product
7.1 Glucose Monitoring
 7.1.1 Overview
 7.1.2 Glucose Monitoring: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Infectious Disease Testing
 7.2.1 Overview
 7.2.2 Infectious Disease Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Cardio metabolic Testing
 7.3.1 Overview
 7.3.2 Cardio metabolic Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
 7.4.1 Overview
 7.4.2 Pregnancy And Fertility Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Coagulation Testing
 7.5.1 Overview
 7.5.2 Coagulation Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
 7.6.1 Overview
 7.6.2 Tumor or Cancer Marker Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.7 Cholesterol Testing
 7.7.1 Overview
 7.7.2 Cholesterol Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.8 Urinalysis Testing
 7.8.1 Overview
 7.8.2 Urinalysis Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.9 Hematology Testing
 7.9.1 Overview
 7.9.2 Hematology Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.10 Thyroid Testing
 7.10.1 Overview
 7.10.2 Thyroid Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.11 Others
 7.11.1 Overview
 7.11.2 Others: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8. Point of Care Diagnostics Market Analysis - by Purchase Mode
8.1 OTC
 8.1.1 Overview
 8.1.2 OTC: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Prescription
 8.2.1 Overview
 8.2.2 Prescription: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
9. Point of Care Diagnostics Market Analysis - by Sample
9.1 Blood
 9.1.1 Overview
 9.1.2 Blood: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Urine
 9.2.1 Overview
 9.2.2 Urine: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
 9.3.1 Overview
 9.3.2 Others: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
10. Point of Care Diagnostics Market Analysis - by End User
10.1 Healthcare Facilities
 10.1.1 Overview
 10.1.2 Healthcare Facilities: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Homecare
 10.2.1 Overview
 10.2.2 Homecare: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Others
 10.3.1 Overview
 10.3.2 Others: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
11. Point of Care Diagnostics Market - Geographical Analysis
11.1 Overview
11.2 North America
 11.2.1 North America Point of Care Diagnostics Market Overview
 11.2.2 North America: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.2.3 North America: Point of Care Diagnostics Market Breakdown, by Product
 11.2.3.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
 11.2.3.2 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
 11.2.3.3 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
 11.2.3.4 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
 11.2.4 North America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.2.4.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
 11.2.5 North America: Point of Care Diagnostics Market Breakdown, by Sample
 11.2.5.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
 11.2.6 North America: Point of Care Diagnostics Market Breakdown, by End User
 11.2.6.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
 11.2.6.2 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
 11.2.7 North America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
 11.2.7.1 North America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
 11.2.7.2 United States: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.2.7.2.1 United States: Point of Care Diagnostics Market Breakdown, by Product
 11.2.7.2.2 United States: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.2.7.2.3 United States: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.2.7.2.4 United States: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.2.7.2.5 United States: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.2.7.2.6 United States: Point of Care Diagnostics Market Breakdown, by Sample
 11.2.7.2.7 United States: Point of Care Diagnostics Market Breakdown, by End User
 11.2.7.2.8 United States: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.2.7.3 Canada: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.2.7.3.1 Canada: Point of Care Diagnostics Market Breakdown, by Product
 11.2.7.3.2 Canada: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.2.7.3.3 Canada: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.2.7.3.4 Canada: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.2.7.3.5 Canada: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.2.7.3.6 Canada: Point of Care Diagnostics Market Breakdown, by Sample
 11.2.7.3.7 Canada: Point of Care Diagnostics Market Breakdown, by End User
 11.2.7.3.8 Canada: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.2.7.4 Mexico: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.2.7.4.1 Mexico: Point of Care Diagnostics Market Breakdown, by Product
 11.2.7.4.2 Mexico: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.2.7.4.3 Mexico: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.2.7.4.4 Mexico: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.2.7.4.5 Mexico: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.2.7.4.6 Mexico: Point of Care Diagnostics Market Breakdown, by Sample
 11.2.7.4.7 Mexico: Point of Care Diagnostics Market Breakdown, by End User
 11.2.7.4.8 Mexico: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3 Europe
 11.3.1 EuropePoint of Care Diagnostics Market Overview
 11.3.2 Europe: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.3.3 Europe: Point of Care Diagnostics Market Breakdown, by Product
 11.3.3.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
 11.3.3.2 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
 11.3.3.3 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
 11.3.3.4 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
 11.3.4 Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.3.4.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
 11.3.5 Europe: Point of Care Diagnostics Market Breakdown, by Sample
 11.3.5.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
 11.3.6 Europe: Point of Care Diagnostics Market Breakdown, by End User
 11.3.6.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
 11.3.6.2 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
 11.3.7 Europe: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
 11.3.7.1 Europe: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
 11.3.7.2 United Kingdom: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.3.7.2.1 United Kingdom: Point of Care Diagnostics Market Breakdown, by Product
 11.3.7.2.2 United Kingdom: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.3.7.2.3 United Kingdom: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.3.7.2.4 United Kingdom: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.3.7.2.5 United Kingdom: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.3.7.2.6 United Kingdom: Point of Care Diagnostics Market Breakdown, by Sample
 11.3.7.2.7 United Kingdom: Point of Care Diagnostics Market Breakdown, by End User
 11.3.7.2.8 United Kingdom: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.3.7.3 Germany: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.3.7.3.1 Germany: Point of Care Diagnostics Market Breakdown, by Product
 11.3.7.3.2 Germany: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.3.7.3.3 Germany: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.3.7.3.4 Germany: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.3.7.3.5 Germany: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.3.7.3.6 Germany: Point of Care Diagnostics Market Breakdown, by Sample
 11.3.7.3.7 Germany: Point of Care Diagnostics Market Breakdown, by End User
 11.3.7.3.8 Germany: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.3.7.4 France: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.3.7.4.1 France: Point of Care Diagnostics Market Breakdown, by Product
 11.3.7.4.2 France: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.3.7.4.3 France: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.3.7.4.4 France: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.3.7.4.5 France: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.3.7.4.6 France: Point of Care Diagnostics Market Breakdown, by Sample
 11.3.7.4.7 France: Point of Care Diagnostics Market Breakdown, by End User
 11.3.7.4.8 France: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.3.7.5 Italy: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.3.7.5.1 Italy: Point of Care Diagnostics Market Breakdown, by Product
 11.3.7.5.2 Italy: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.3.7.5.3 Italy: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.3.7.5.4 Italy: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.3.7.5.5 Italy: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.3.7.5.6 Italy: Point of Care Diagnostics Market Breakdown, by Sample
 11.3.7.5.7 Italy: Point of Care Diagnostics Market Breakdown, by End User
 11.3.7.5.8 Italy: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.3.7.6 Spain: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.3.7.6.1 Spain: Point of Care Diagnostics Market Breakdown, by Product
 11.3.7.6.2 Spain: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.3.7.6.3 Spain: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.3.7.6.4 Spain: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.3.7.6.5 Spain: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.3.7.6.6 Spain: Point of Care Diagnostics Market Breakdown, by Sample
 11.3.7.6.7 Spain: Point of Care Diagnostics Market Breakdown, by End User
 11.3.7.6.8 Spain: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.3.7.7 Rest of Europe: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.3.7.7.1 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Product
 11.3.7.7.2 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.3.7.7.3 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.3.7.7.4 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.3.7.7.5 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.3.7.7.6 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Sample
 11.3.7.7.7 Rest of Europe: Point of Care Diagnostics Market Breakdown, by End User
 11.3.7.7.8 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4 Asia Pacific
 11.4.1 Asia PacificPoint of Care Diagnostics Market Overview
 11.4.2 Asia Pacific: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.4.3 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Product
 11.4.3.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
 11.4.3.2 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
 11.4.3.3 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
 11.4.3.4 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
 11.4.4 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.4.4.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
 11.4.5 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Sample
 11.4.5.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
 11.4.6 Asia Pacific: Point of Care Diagnostics Market Breakdown, by End User
 11.4.6.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
 11.4.6.2 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
 11.4.7 Asia Pacific: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
 11.4.7.1 Asia Pacific: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
 11.4.7.2 China: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.4.7.2.1 China: Point of Care Diagnostics Market Breakdown, by Product
 11.4.7.2.2 China: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.4.7.2.3 China: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.4.7.2.4 China: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.4.7.2.5 China: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.4.7.2.6 China: Point of Care Diagnostics Market Breakdown, by Sample
 11.4.7.2.7 China: Point of Care Diagnostics Market Breakdown, by End User
 11.4.7.2.8 China: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.4.7.3 Japan: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.4.7.3.1 Japan: Point of Care Diagnostics Market Breakdown, by Product
 11.4.7.3.2 Japan: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.4.7.3.3 Japan: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.4.7.3.4 Japan: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.4.7.3.5 Japan: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.4.7.3.6 Japan: Point of Care Diagnostics Market Breakdown, by Sample
 11.4.7.3.7 Japan: Point of Care Diagnostics Market Breakdown, by End User
 11.4.7.3.8 Japan: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.4.7.4 India: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.4.7.4.1 India: Point of Care Diagnostics Market Breakdown, by Product
 11.4.7.4.2 India: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.4.7.4.3 India: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.4.7.4.4 India: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.4.7.4.5 India: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.4.7.4.6 India: Point of Care Diagnostics Market Breakdown, by Sample
 11.4.7.4.7 India: Point of Care Diagnostics Market Breakdown, by End User
 11.4.7.4.8 India: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.4.7.5 Australia: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.4.7.5.1 Australia: Point of Care Diagnostics Market Breakdown, by Product
 11.4.7.5.2 Australia: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.4.7.5.3 Australia: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.4.7.5.4 Australia: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.4.7.5.5 Australia: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.4.7.5.6 Australia: Point of Care Diagnostics Market Breakdown, by Sample
 11.4.7.5.7 Australia: Point of Care Diagnostics Market Breakdown, by End User
 11.4.7.5.8 Australia: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.4.7.6 South Korea: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.4.7.6.1 South Korea: Point of Care Diagnostics Market Breakdown, by Product
 11.4.7.6.2 South Korea: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.4.7.6.3 South Korea: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.4.7.6.4 South Korea: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.4.7.6.5 South Korea: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.4.7.6.6 South Korea: Point of Care Diagnostics Market Breakdown, by Sample
 11.4.7.6.7 South Korea: Point of Care Diagnostics Market Breakdown, by End User
 11.4.7.6.8 South Korea: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.4.7.7 Rest of APAC: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.4.7.7.1 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Product
 11.4.7.7.2 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.4.7.7.3 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.4.7.7.4 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.4.7.7.5 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.4.7.7.6 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Sample
 11.4.7.7.7 Rest of APAC: Point of Care Diagnostics Market Breakdown, by End User
 11.4.7.7.8 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.5 Middle East and Africa
 11.5.1 Middle East and AfricaPoint of Care Diagnostics Market Overview
 11.5.2 Middle East and Africa: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.5.3 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product
 11.5.3.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
 11.5.3.2 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
 11.5.3.3 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
 11.5.3.4 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
 11.5.4 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.5.4.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
 11.5.5 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample
 11.5.5.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
 11.5.6 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User
 11.5.6.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
 11.5.6.2 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
 11.5.7 Middle East and Africa: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
 11.5.7.1 Middle East and Africa: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
 11.5.7.2 South Africa: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.5.7.2.1 South Africa: Point of Care Diagnostics Market Breakdown, by Product
 11.5.7.2.2 South Africa: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.5.7.2.3 South Africa: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.5.7.2.4 South Africa: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.5.7.2.5 South Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.5.7.2.6 South Africa: Point of Care Diagnostics Market Breakdown, by Sample
 11.5.7.2.7 South Africa: Point of Care Diagnostics Market Breakdown, by End User
 11.5.7.2.8 South Africa: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.5.7.3 Saudi Arabia: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.5.7.3.1 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Product
 11.5.7.3.2 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.5.7.3.3 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.5.7.3.4 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.5.7.3.5 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.5.7.3.6 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Sample
 11.5.7.3.7 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by End User
 11.5.7.3.8 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.5.7.4 United Arab Emirates: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.5.7.4.1 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Product
 11.5.7.4.2 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.5.7.4.3 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.5.7.4.4 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.5.7.4.5 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.5.7.4.6 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Sample
 11.5.7.4.7 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by End User
 11.5.7.4.8 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.5.7.5 Rest of Middle East and Africa: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.5.7.5.1 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product
 11.5.7.5.2 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.5.7.5.3 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.5.7.5.4 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.5.7.5.5 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.5.7.5.6 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample
 11.5.7.5.7 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User
 11.5.7.5.8 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.6 South and Central America
 11.6.1 South and Central America Point of Care Diagnostics Market Overview
 11.6.2 South and Central America: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.6.3 South and Central America: Point of Care Diagnostics Market Breakdown, by Product
 11.6.3.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
 11.6.3.2 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
 11.6.3.3 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
 11.6.3.4 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
 11.6.4 South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.6.4.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
 11.6.5 South and Central America: Point of Care Diagnostics Market Breakdown, by Sample
 11.6.5.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
 11.6.6 South and Central America: Point of Care Diagnostics Market Breakdown, by End User
 11.6.6.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
 11.6.6.2 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
 11.6.7 South and Central America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
 11.6.7.1 South and Central America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
 11.6.7.2 Brazil: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.6.7.2.1 Brazil: Point of Care Diagnostics Market Breakdown, by Product
 11.6.7.2.2 Brazil: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.6.7.2.3 Brazil: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.6.7.2.4 Brazil: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.6.7.2.5 Brazil: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.6.7.2.6 Brazil: Point of Care Diagnostics Market Breakdown, by Sample
 11.6.7.2.7 Brazil: Point of Care Diagnostics Market Breakdown, by End User
 11.6.7.2.8 Brazil: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.6.7.3 Argentina: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.6.7.3.1 Argentina: Point of Care Diagnostics Market Breakdown, by Product
 11.6.7.3.2 Argentina: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.6.7.3.3 Argentina: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.6.7.3.4 Argentina: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.6.7.3.5 Argentina: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.6.7.3.6 Argentina: Point of Care Diagnostics Market Breakdown, by Sample
 11.6.7.3.7 Argentina: Point of Care Diagnostics Market Breakdown, by End User
 11.6.7.3.8 Argentina: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
 11.6.7.4 Rest of South and Central America: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
 11.6.7.4.1 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Product
 11.6.7.4.2 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
 11.6.7.4.3 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
 11.6.7.4.4 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
 11.6.7.4.5 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
 11.6.7.4.6 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Sample
 11.6.7.4.7 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by End User
 11.6.7.4.8 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Market Share Analysis, 2024
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Merger and Acquisition
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd
 14.1.1 Key Facts
 14.1.2 Business Description
 14.1.3 Products and Services
 14.1.4 Financial Overview
 14.1.5 SWOT Analysis
 14.1.6 Key Developments
14.2 Beckman Coulter Inc
 14.2.1 Key Facts
 14.2.2 Business Description
 14.2.3 Products and Services
 14.2.4 Financial Overview
 14.2.5 SWOT Analysis
 14.2.6 Key Developments
14.3 Bio-Rad Laboratories Inc
 14.3.1 Key Facts
 14.3.2 Business Description
 14.3.3 Products and Services
 14.3.4 Financial Overview
 14.3.5 SWOT Analysis
 14.3.6 Key Developments
14.4 Abbott Laboratories
 14.4.1 Key Facts
 14.4.2 Business Description
 14.4.3 Products and Services
 14.4.4 Financial Overview
 14.4.5 SWOT Analysis
 14.4.6 Key Developments
14.5 Johnson & Johnson
 14.5.1 Key Facts
 14.5.2 Business Description
 14.5.3 Products and Services
 14.5.4 Financial Overview
 14.5.5 SWOT Analysis
 14.5.6 Key Developments
14.6 Siemens AG
 14.6.1 Key Facts
 14.6.2 Business Description
 14.6.3 Products and Services
 14.6.4 Financial Overview
 14.6.5 SWOT Analysis
 14.6.6 Key Developments
14.7 BD
 14.7.1 Key Facts
 14.7.2 Business Description
 14.7.3 Products and Services
 14.7.4 Financial Overview
 14.7.5 SWOT Analysis
 14.7.6 Key Developments
14.8 bioMerieux SA
 14.8.1 Key Facts
 14.8.2 Business Description
 14.8.3 Products and Services
 14.8.4 Financial Overview
 14.8.5 SWOT Analysis
 14.8.6 Key Developments
14.9 Polymer Technology Systems, Inc. (PTS)
 14.9.1 Key Facts
 14.9.2 Business Description
 14.9.3 Products and Services
 14.9.4 Financial Overview
 14.9.5 SWOT Analysis
 14.9.6 Key Developments
14.10 Nova Biomedical Corporation
 14.10.1 Key Facts
 14.10.2 Business Description
 14.10.3 Products and Services
 14.10.4 Financial Overview
 14.10.5 SWOT Analysis
 14.10.6 Key Developments
14.11 Talis Biomedical Corporation
 14.11.1 Key Facts
 14.11.2 Business Description
 14.11.3 Products and Services
 14.11.4 Financial Overview
 14.11.5 SWOT Analysis
 14.11.6 Key Developments
14.12 QuidelOrtho Corp
 14.12.1 Key Facts
 14.12.2 Business Description
 14.12.3 Products and Services
 14.12.4 Financial Overview
 14.12.5 SWOT Analysis
 14.12.6 Key Developments
14.13 Chembio Diagnostics, Inc.
 14.13.1 Key Facts
 14.13.2 Business Description
 14.13.3 Products and Services
 14.13.4 Financial Overview
 14.13.5 SWOT Analysis
 14.13.6 Key Developments
15. Appendix
15.1 About
LIST OF TABLES
Table 1. Point of Care Diagnostics Market Segmentation
Table 2. List of Vendors
Table 3. Point of Care Diagnostics Market - Revenue, 2021- 2024 (US$ Million)
Table 4. Point of Care Diagnostics Market - Revenue, 2025- 2031 (US$ Million)
Table 5. Point of Care Diagnostics Market - Revenue, 2021 -2024(US$ Million) - by Product
Table 6. Point of Care Diagnostics Market - Revenue, 2025 - 2031(US$ Million) - by Product
Table 7. Point of Care Diagnostics Market - Revenue, 2021 -2024(US$ Million) - by Purchase Mode
Table 8. Point of Care Diagnostics Market - Revenue, 2025 - 2031(US$ Million) - by Purchase Mode
Table 9. Point of Care Diagnostics Market - Revenu
LIST OF FIGURES
The List of Companies - Point of Care Diagnostics Market
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories Inc
- Abbott Laboratories
- QIAGEN NV
- Siemens AG
- BD
- bioMerieux SA
- Polymer Technology Systems, Inc. (PTS)
- Nova Biomedical Corporation
- Danaher Corp